Cargando…

Antiproliferative and Antioxidant Effects of Withania coagulans Extract on Benign Prostatic Hyperplasia in Rats

BACKGROUND: Benign prostate hyperplasia (BPH) is a common urological disorder in elderly men. Phytotherapy is frequently used to alleviate the symptoms of this condition. OBJECTIVES: The present study investigated the effect of Withania coagulans extract (WCE), which is known to have antioxidant, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarbishegi, Maryam, Khani, Mohaddeseh, Salimi, Saeedeh, Valizadeh, Mohharam, Sargolzaei Aval, Fereydoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779590/ https://www.ncbi.nlm.nih.gov/pubmed/26981498 http://dx.doi.org/10.5812/numonthly.33180

Ejemplares similares

Withania coagulans Extract Induces Cell Apoptosis and Inhibits COX-2 Expression in a Rat Model of Benign Prostatic Hyperplasia
por: Sarbishegi, Maryam, et al.
Publicado: (2016)

Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats
por: Sarbishegi, Maryam, et al.
Publicado: (2016)

Withania Coagulans and Somnifera
por: Verghese, M.
Publicado: (1885)

Agrobacterium-Mediated Genetic Transformation of Withania coagulans (Dunal) with rol A Genes and Its Antioxidant Potential
por: Rehman, Samiya, et al.
Publicado: (2023)

Protective Effect of Withania coagulans Fruit Extract on Cisplatin-induced Nephrotoxicity in Rats
por: Sharma, Sonam, et al.
Publicado: (2017)

Isolation of Antidiabetic Withanolides from Withania coagulans Dunal and Their In Vitro and In Silico Validation
por: Maher, Saima, et al.
Publicado: (2020)

Evaluation of the Antidiabetic Potential of an Isolated Hydroalcoholic Fraction from the Fruit of Withania coagulans
por: Waris, Md., et al.
Publicado: (2021)

The effects of camel chymosin and Withania coagulans extract on camel and bovine milk cheeses
por: Mbye, Mustapha, et al.
Publicado: (2021)

Fractionation of Biomolecules in Withania coagulans Extract for Bioreductive Nanoparticle Synthesis, Antifungal and Biofilm Activity
por: Hasan, Murtaza, et al.
Publicado: (2020)

Phytochemistry, Food Application, and Therapeutic Potential of the Medicinal Plant (Withania coagulans): A Review
por: Khan, Muhammad Issa, et al.
Publicado: (2021)

The Protective Effects of Gadolinum Chloride on Pneumotoxic Effects of Styrene in Rat
por: Arab, Mohammad Reza, et al.
Publicado: (2015)

Efficacy of Octacalcium Phosphate and Octacalcium Phosphate/Gelatin Composite on the Repair of Critical-Sized Calvarial Defects in Rats
por: Sargolzaei Aval, Fereydoon, et al.
Publicado: (2018)

Proliferation, odontogenic/osteogenic differentiation, and cytokine production by human stem cells of the apical papilla induced by biomaterials: a comparative study
por: Saberi, Eshaghali, et al.
Publicado: (2019)

Benign Prostatic Hyperplasia
Publicado: (2015)

A clinical study on the effect of Rishyagandha (Withania coagulans) in the management of Prameha (Type II Diabetes Mellitus)
por: Upadhyay, B. N., et al.
Publicado: (2011)

Withania coagulans Fruit Extract Reduces Oxidative Stress and Inflammation in Kidneys of Streptozotocin-Induced Diabetic Rats
por: Ojha, Shreesh, et al.
Publicado: (2014)

Antidiabetic and antihyperlipidemic activity of hydroalcoholic extract of Withania coagulans Dunal dried fruit in experimental rat models
por: Datta, Ankur, et al.
Publicado: (2013)

Preparation, Characterization of Pregabalin and Withania coagulans Extract-Loaded Topical Gel and Their Comparative Effect on Burn Injury
por: Asghar, Anam, et al.
Publicado: (2022)

Octacalcium phosphate/gelatin composite facilitates bone regeneration of critical-sized mandibular defects in rats: A quantitative study
por: Sargolzaei-Aval, Fereydoon, et al.
Publicado: (2019)

Evaluation of apoptotic activity of Withania coagulans methanolic extract against human breast cancer and Vero cell lines
por: Ahmad, Rumana, et al.
Publicado: (2017)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Improvements in HOMA indices and pancreatic endocrinal tissues in type 2-diabetic rats by DPP-4 inhibition and antioxidant potential of an ethanol fruit extract of Withania coagulans
por: Ram, Heera, et al.
Publicado: (2021)

Reconstruction of mandibular defects using synthetic octacalcium phosphate combined with bone matrix gelatin in rat model
por: Sargolzaei-Aval, Fereydoon, et al.
Publicado: (2020)

Small-Intestine-Specific Delivery of Antidiabetic Extracts from Withania coagulans Using Polysaccharide-Based Enteric-Coated Nanoparticles
por: Sampathkumar, Kaarunya, et al.
Publicado: (2019)

In Silico Characterization of Withania coagulans Bioactive Compounds as Potential Inhibitors of Hydroxymethylglutaryl (HMG-CoA) Reductase of Mus musculus
por: Azmi, Muhammad Bilal, et al.
Publicado: (2023)

Melatonin Confers NaCl Tolerance in Withania coagulans L. by Maintaining Na(+)/K(+) Homeostasis, Strengthening the Antioxidant Defense System and Modulating Withanolides Synthesis-Related Genes
por: Dehvari-Nagan, P., et al.
Publicado: (2023)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Antioxidant mitoquinone suppresses benign prostatic hyperplasia by regulating the AR–NLRP3 pathway
por: Jin, Bo-Ram, et al.
Publicado: (2023)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_n7fmhpf7pdgjvm0kcd1kv1ot11